S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
3 Value Stocks Too Small For Buffett’s Portfolio
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
Foot Locker Builds Up Another Head of Steam; Gains Imminent
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
3 Value Stocks Too Small For Buffett’s Portfolio
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
Foot Locker Builds Up Another Head of Steam; Gains Imminent
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
3 Value Stocks Too Small For Buffett’s Portfolio
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
Foot Locker Builds Up Another Head of Steam; Gains Imminent
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
3 Value Stocks Too Small For Buffett’s Portfolio
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
Foot Locker Builds Up Another Head of Steam; Gains Imminent
OTCMKTS:PBIO

Pressure BioSciences (PBIO) Stock Price, News & Analysis

$0.18
+0.02 (+12.50%)
(As of 03/28/2024 ET)
Today's Range
$0.17
$0.18
50-Day Range
$0.14
$0.42
52-Week Range
$0.14
$1.37
Volume
57,634 shs
Average Volume
103,150 shs
Market Capitalization
$5.59 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
PBIO stock logo

About Pressure BioSciences Stock (OTCMKTS:PBIO)

Pressure BioSciences, Inc. develops and sells pressure-based platform solutions in the North America, Europe, and Asia. The company's pressure cycling technology (PCT) technology uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to control the actions of molecules in biological samples, including cells and tissues from human, animal, plant, and microbial sources. It offers Barocycler instrumentations comprising Barocycler 2320EXT, Barocycler HUB880, Barocycler HUB440, and the Shredder SG3. The company also distributes cell disruption equipment, parts, and consumables. In addition, it offers Barocycler consumable products, such as PCT MicroTubes, PCT MicroCaps, PCT-Micro Pestle, and pressure used to lyse samples for extraction tubes, as well as application specific kits, including consumable products and reagents. The company serves researchers at academic laboratories, government agencies, biotechnology companies, pharmaceutical firms, and other life science institutions. It has collaborations with RedShiftBio Inc.; Inova Schar Cancer Center; NYU; Leica Microsystems, GmbH; Steinbeis Centre for biopolymer analysis and biological mass spectrometry; The Ohio State University; University of Delaware; and Cedars Sinai Medical Center. The company was formerly known as Boston Biomedica, Inc. and changed its name to Pressure BioSciences, Inc. in September 2014. The company was incorporated in 1978 and is based in South Easton, Massachusetts.

PBIO Stock Price History

PBIO Stock News Headlines

The Best Pressure Washer
Central Banks Preparing for US Dollar Collapse?
China is spearheading this blatant de-dollarization push, dominating the physical gold market through massive central bank buying. Their ultimate goal? Ditching the greenback in favor of local BRICS currencies.
Central Banks Preparing for US Dollar Collapse?
China is spearheading this blatant de-dollarization push, dominating the physical gold market through massive central bank buying. Their ultimate goal? Ditching the greenback in favor of local BRICS currencies.
Best Blood Pressure Monitors For 2024
Pressure BioSciences To Acquire Uncle Bud's - Quick Facts
See More Headlines
Receive PBIO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pressure BioSciences and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/17/2020
Today
3/29/2024
Next Earnings (Estimated)
4/16/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Analytical instruments
Sub-Industry
N/A
Current Symbol
OTCMKTS:PBIO
Employees
16
Year Founded
N/A

Profitability

Net Income
$-16,080,000.00
Net Margins
-1,050.11%
Pretax Margin
-1,050.15%

Debt

Sales & Book Value

Annual Sales
$1.73 million
Book Value
($2.56) per share

Miscellaneous

Free Float
27,697,000
Market Cap
$5.59 million
Optionable
Not Optionable
Beta
-0.10
(Almost) Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Key Executives

  • Mr. Richard T. Schumacher (Age 74)
    Founder, President, CEO, Treasurer, Interim CFO, Clerk & Director
    Comp: $320.54k
  • Dr. Edmund Y. Ting Ph.D. (Age 69)
    Sc.D. Ph.D., Senior Vice President of Engineering
    Comp: $215.16k
  • Dr. Alexander V. Lazarev Ph.D. (Age 59)
    Vice President of Research & Development
    Comp: $202.27k
  • John B. Hollister
    Director of Sales & Marketing

PBIO Stock Analysis - Frequently Asked Questions

How have PBIO shares performed in 2024?

Pressure BioSciences' stock was trading at $0.33 at the beginning of 2024. Since then, PBIO stock has decreased by 45.5% and is now trading at $0.18.
View the best growth stocks for 2024 here
.

Are investors shorting Pressure BioSciences?

Pressure BioSciences saw a increase in short interest in the month of March. As of March 15th, there was short interest totaling 23,700 shares, an increase of 121.5% from the February 29th total of 10,700 shares. Based on an average daily trading volume, of 203,200 shares, the short-interest ratio is presently 0.1 days.
View Pressure BioSciences' Short Interest
.

When is Pressure BioSciences' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, April 16th 2024.
View our PBIO earnings forecast
.

How were Pressure BioSciences' earnings last quarter?

Pressure BioSciences, Inc. (OTCMKTS:PBIO) announced its quarterly earnings data on Tuesday, November, 17th. The company reported ($1.02) earnings per share for the quarter, topping the consensus estimate of ($2.20) by $1.18. The business earned $0.53 million during the quarter.
Read the conference call transcript
.

What other stocks do shareholders of Pressure BioSciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Pressure BioSciences investors own include Advanced Micro Devices (AMD), Allena Pharmaceuticals (ALNA), Actinium Pharmaceuticals (ATNM), Anavex Life Sciences (AVXL), Aware (AWRE), Curaleaf (CURLF) and Walt Disney (DIS).

How do I buy shares of Pressure BioSciences?

Shares of PBIO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:PBIO) was last updated on 3/29/2024 by MarketBeat.com Staff

From Our Partners